Odi Bruckman

@odibro

BioPharma Stock News

Tel Aviv
Vrijeme pridruživanja: ožujak 2010.

Tweetovi

Blokirali ste korisnika/cu @odibro

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @odibro

  1. prije 1 minutu

    Announces FDA Clearance of IND Application for BXCL501 for the Treatment of Opioid Withdrawal Symptoms Company is preparing to initiate Phase 1b/2 RELEASE trial

    Poništi
  2. prije 9 minuta

    Kevin Ali to be named CEO for NewCo

    Poništi
  3. prije 13 minuta
    Poništi
  4. prije 16 minuta

    to Focus on Key Growth Pillars Through Spinoff of Women’s Health, Trusted Legacy Brands and Biosimilars Products into New Company (“NewCo”)

    Poništi
  5. proslijedio/la je Tweet

    2020 was supposed to be the year the dollar finally weakened versus its global peers. Instead, it has steadily strengthened and is poised to continue to do so today, despite the broader risk-on feel in markets.

    Poništi
  6. prije 36 minuta

    upgraded to Outperform from Market Perform at JMP. $10 PT

    Poništi
  7. proslijedio/la je Tweet

    cell therapy pipeline

    Prikaži ovu nit
    Poništi
  8. prije 44 minute

    initiated with a Buy at Nomura. $27 PT

    Poništi
  9. prije 52 minute

    eliminated the position of Chief Business Development and Supply Chain Officer

    Poništi
  10. proslijedio/la je Tweet

    Chinese equities eke out gains after Monday’s $720 billion rout

    Poništi
  11. 3. velj
    Poništi
  12. 3. velj

    CureTech’s Cancer-Fighting Dreams End With Insolvency

    Poništi
  13. 3. velj

    Signs Ex. License Agreement with Equinox Science to Develop TKI Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion. $1M payment to Equinox

    Poništi
  14. proslijedio/la je Tweet
    3. velj

    A little bit of good news about coronavirus: The number of new cases outside mainland China is currently declining: Jan. 31: 28 new cases Feb. 1: 14 new cases Feb. 2: 11 new cases Feb. 3: 6 new cases

    Poništi
  15. 3. velj
    Poništi
  16. proslijedio/la je Tweet
    3. velj

    Biotech updates 02/03: Ph2 +ve data +41% Fast track desig+15% offering -12% AH Phase 2/3 SCLC fail -2% 1:20 reverse split (02/11) Pipeline updates:

    Poništi
  17. 3. velj
    Poništi
  18. 3. velj

    appoints Shalini Sharp to BOD ; ($RARE CFO)

    Poništi
  19. 3. velj
    Poništi
  20. proslijedio/la je Tweet
    3. velj

    BioNTech announces 6M ADS offering through JPMorgan, BofA, Berenberg, SVB Leerink - F-1

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·